Skip to main content
2024 AAOMS 106th Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed <br><i>This session/event requires a ticket.</i>
Ticketed
This session/event requires a ticket.
In-person only<br><i>This session is offered in-person only.</i>
In-person only
This session is offered in-person only.
On-demand<br><i>On-demand session available beginning Sept. 9.</i>
On-demand
On-demand session available beginning Sept. 9.
Recorded<br><i>This session will be recorded and available beginning Sept. 30.</i>
Recorded
This session will be recorded and available beginning Sept. 30.
Sold Out<br><i>This ticketed session/event is sold out.</i>
Sold Out
This ticketed session/event is sold out.
2024 Oral Abstract Award
2024 Oral Abstract Award
Poster Icons
Poster Winner
Poster Winner
Back

Marcus Couey, DDS, MD (he/him/his)

Assistant Professor and Fellowship Director, Oncologic and Microvascular Reconstructive Surgery
Boston University
Boston, Massachusetts

Dr. Couey is Assistant Professor in the Department of Oral and Maxillofacial Surgery at Boston University. He earned his DDS from Columbia University and his MD from the University of Texas, Houston. Following surgical residency training at UT Houston, he completed a research fellowship in Immuno-Oncology at the Earle A. Chiles Research Institute in Portland, OR, where he focused on the development of immuno-oncology clinical trials, immunotherapy toxicity and biomarkers for response to immunotherapy. He went on to complete fellowship training in Head and Neck Oncologic Surgery and Microvascular Reconstructive Surgery at Providence Cancer Institute in Portland, OR.

Dr. Couey specializes in the management of cancers involving the mouth, throat, and salivary glands, benign jaw tumors, facial trauma, and microvascular reconstructive surgery. He is active in oncology research, and has published numerous peer-reviewed articles, textbook chapters and abstracts. In addition to providing high-level care for complex maxillofacial pathologies, he aims to develop new treatment strategies that incorporate immunotherapy to improve outcomes for patients with head and neck cancer.

Presentation(s):